Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Onconetix (ONCO) Cost of Revenue (2024 - 2025)

Onconetix (ONCO) has disclosed Cost of Revenue for 1 consecutive years, with $52008.0 as the latest value for Q4 2024.

  • On a quarterly basis, Cost of Revenue changed N/A to $52008.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1.5 million, a N/A change, with the full-year FY2024 number at $1.5 million, up 23.9% from a year prior.
  • Cost of Revenue was $52008.0 for Q4 2024 at Onconetix, down from $301445.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $604132.0 in Q2 2024 to a low of $52008.0 in Q4 2024.